Johnson & Johnson

US: Johnson & Johnson ordered to pay $8bn over male breast growth

Multinational company Johnson & Johnson has been ordered to pay $8 billion in punitive damages to a man who said the firm had not issued a warning that its antipsychotic drug could lead to breast growth.

Published 9 October 2019

Johnson & Johnson's share price rises after opioid scandal fines

Drugmaker Johnson & Johnson's share prices have risen following an order for the company to pay $572m (£468m) for its role in the opioid addiction crisis.

Published 27 August 2019